MYRIAD GENETICS INC — Form 8-K
Filed October 9, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Brian Donnelly, Chief Commercial Officer, separated from Myriad on September 21, 2026. The company paid $1,322,294 in severance (base salary $576,800 + target bonus $432,600 + pro-rata bonus $312,894), plus one year of COBRA coverage. Equity awards vest through September 2028. Donnelly signed a broad release of all employment claims effective October 6, 2026.
Why this rating
Executive departure with standard severance (~0.27% of $494M market cap). No indication of controversy, strategy shift, or material operational disruption. Routine C-suite transition.
See more from October 9, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.